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Women's Health Research at
NIEHS
The fact that the majority of the popula-
tion, women, are understudied in biomed-
ical science remains a scientific anomaly,
one that the National Institutes of Health
has resolved to remedy. Within NIH,
NIEHS has a long history of interest in
women's health including studies on
diethylstilbestrol, estrogens in the environ-
ment, cancer, fertility, and reproductive
health. Today, NIEHS approaches wom-
en's health with a renewed emphasis, with
an even greater dedication not only to dis-
ease and dysfunction relating to women
and their reproductive role, but to those
illnesses disproportionately affecting
women such as breast cancer, osteoporosist'
endometriosis, leiomyoma (fibroid t'-1
mors), and lupus.
The "NIEHS News" section d this
issue focuses on NIEHS initiasin-
women's health, highlighting variou
eases and dysfunctions disproportionately
affecting women and discussing NIEHS
research directed at those concerns.
The importance of a women's health
agenda is driven by three facts: Over a life-
time, women's health is generally worse
than men's, certain health problems are
more prevalent in women than in men,
and certain health problems are unique to
women or affect women differently than
men. Knowledge concerning the causes,
expression, and treatment ofmany diseases
has frequently been derived from studies of
men under the assumption that there are
no significant sex-based differences, even
though, for example, cardiovascular disease
accounts for a higher percentage of deaths
among women than men in all stages of
life. In regard to death from gender-specif-
ic disease, nearly one-third of all cancer
deaths in women are due to malignancies
of the breast, ovary, uterine cervix, and
uterine endometrium. Approximately one
in nine women will be diagnosed with
breast cancer during her lifetime.
The general health of women is dra-
matically affected by nonfatal diseases and
dysfunctions. Frequently occurring dis-
eases that are unique to women include
endometriosis and leiomyoma of the
uterus, which affect up to 20-30% of the
female population and for which the causes
remain obscure. Among diseases common
to both sexes, women suffer inordinately
from osteoporosis, which affects a majority
ofwomen over age 60, and from immuno-
logic disorders including rheumatoid
arthritis, diabetes mellitus, multiple sclero-
sis, systemic lupus erythematosus, and
autoimmune thyroid diseases, all ofwhich
are more prevalent in women than in men.
In addition, neurologic conditions such as
Alzheimer's disease and various affective
disorders are more common among
females.
As increasingly more women enter the
workforce, they may be exposed to a vari-
ety of occupational chemicals and hazards
that may lead to adverse health and repro-
ductive effects. In addir;rWi6nsm`ig
alcohol consumption,
factors play an incres mptaD
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risk factor for many gynecologic malig-
nancies, as well as benign proliferative
disorders such as endometriosis and
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an uncertain risk for cardiovascular dis-
ease and cancer and estrogen replacement
therapy that may be associated with an
increased cancer risk.
* Environmental exposures may aggravate
certain diseases that are more common in
women and which are often assumed
simply to reflect the inevitable conse-
quences of aging. Heavy metals, for
example, have been shown to accelerate
osteoporosis, and numerous environmen-
tal agents are known to be neurotoxic.
The expanded study of environmental
factors in diseases ofwomen is expected to
spawn multiple benefits, not only limited
to the goal of developing new prevention
strategies to decrease disease prevalence
and severity. A heightened understanding
ofthe mechanisms through which environ-
mental agents disrupt normal physiologic
processes will undoubtedly lead to greater
insights into the biological phenomena and
mechanisms. Data on such phenomena
could then be used to design new disease
prevention or treatment strategies. Finally,
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Environmentally Related Cancer in
Women
Approximately27% ofall cancer deaths in
American women are accounted for by
cancers of the breast (44,000 per year),
ovary (12,50)3, uterine endometrium
(5,500),and uterine cervix (4,500).
'Amn ths breast cancer is by far the
biggestkillr, and the death rate from this
diseaseincrased by a disturbing 24%
e 979 and 1986. Although signifi-
cantprogress has been made in defining
genetic factors involved in breast cancer,
f environmental influences
remains largely unexplored. This is partic-
ularly troubling since the recent increase in
breast- incidence is likely to involve
enviroial rather than genetic factors.
Abuda epidemiologic and experimental
data upport the probable role of environ-
mental factors and chemical carcinogens in
the etiology of breast cancer. Currently,
several intramural and extramural research
groups are actively pursuing aspects of
breast carcinogenesis, including studies on
individual differences in carcinogen-
metabolizing enzymes and breast cancer
susceptibility, the definition ofsteroid hor-
mone growth-regulatory pathways in the
mammary gland, the identification of
genetic loci involved in breast cancer devel-
opment, and the role of fat-soluble pesti-
cides as breast carcinogens. Several oppor-
tunities exist for expanding these research
efforts, especially in regard to the interplay
of environmental factors and genetic sus-
ceptibility in the etiology ofbreast cancer.
Ovarian cancer is a relatively common
and highly lethal disease: more than 60%
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ofthe women diagnosed with ovarian can-
cer will die prematurely as a result. Little
is known of the causes of ovarian cancer;
epidemiologic studies suggest that men-
strual, environmental, and genetic factors
are important. Evidence for the role of
environmental factors is primarily popula-
tion based and suggest that dietary factors
and chemical carcinogens are contributors
to increased risk. The intramural and
extramural NIEHS expertise in the areas of
chemical carcinogenesis and growth factor
biology, along with ongoing research pro-
jects in the area ofgenetic predisposition to
ovarian cancer, provide the foundation for
an expanded and productive research agen-
da in this area.
Endometrial carcinoma is the most fre-
quently diagnosed gynecologic malignancy
in the United States, but remains the least
studied of the major cancers affecting
women. Unlike cancers of the breast and
ovary, endometrial cancer is limited pri-
marily to women over the age of 50, and
well-established risk factors suggest proba-
ble etiologic factors, most relating to estro-
gen. Researchers at NIEHS have used
molecular genetic approaches to distin-
guish etiologic factors and animal models
(including transgenic mice) to understand
the role of physiologic and environmental
factors in endometrial carcinogenesis.
Diethylstilbestrol as aModel for
Environmental Estrogens
The health effects of diethylstilbestrol
(DES) exposure are a research priority that
reflects the convergence of several related
investigative projects that are major areas
of concern for NIEHS. The synthetic
estrogen DES was administered to preg-
nant women during the 1940s through
1960s, originally for high-risk pregnancies
but later to promote "healthier babies" as
well. Subsequently, the drug was linked to
the development ofan otherwise extremely
rare malignancy, clear-cell carcinoma of
the vagina, in young female offspring
exposed in utero. In addition, a number of
more common non-neoplastic changes in
the reproductive tract of DES-exposed
daughters were identified, including vagi-
nal adenosis, cervical ectropion, and
numerous other structural abnormalities.
Although the public health hazards associ-
ated with further exposure to DES have
been largely eliminated, there are a number
of compelling reasons for the continued
study of DES-exposed women, as well as
for basic research on the biological effects
of DES and other environmental estro-
genic compounds.
First, it is unclear whether the human
cancer incidence resulting from DES expo-
sure has peaked. Although the majority of
DES daughters have passed the age range
for vaginal carcinoma development, few
have reached the age range (postmeno-
pausal) in which endometrial carcinoma
typically occurs in the DES unexposed
population, and endometrial carcinoma
occurs with a much higher prevalence than
vaginal carcinoma in DES-treated mice.
Similarly, the threat ofbreast cancer is still
a concern in this population. The identifi-
cation of molecular genetic markers for
DES carcinogenicity is therefore a continu-
ing priority; such markers would also be of
value in predicting risk for third-genera-
tion DES offspring, for whom little is
known about potential health risks.
Second, DES may be viewed as a
model compound for other environmental
agents with estrogenic potential. The
bioaccumulation of these environmental
estrogens is recognized as a problem of
increasing magnitude, and certain human
populations in the United States have been
shown to carry amounts of these fat-solu-
ble compounds which, in fish and other
wildlife, cause significant endocrine dys-
function and developmental anomalies of
the reproductive tract. Insights into the
biological effects of DES should therefore
provide a foundation upon which future
environmental health problems may be
effectively addressed.
NIEHS has a long history of accom-
plishments in conducting and supporting
research on estrogen action, hormonal car-
cinogenesis, and other types of estrogen-
related pathology, particularly for DES and
similar compounds. More recent achieve-
ments have provided insights into basic
mechanisms of estrogen receptor action at
the molecular level. A transgenic mouse
that overexpresses the estrogen receptor is
being developed to study tissue susceptibil-
ity and mechanisms for hormonal carcino-
genesis. New endeavors include the analy-
sis of human and animal tumors resulting
from DES exposure in utero for molecular
genetic alterations. Rapid advances in the
fields of molecular and developmental
biology have provided numerous insights
into relevant genes and molecular path-
ways involved in reproductive tract devel-
opment. Epidemiologic studies are fo-
cused on a broad range of health effects
among DES-exposed men and women.
Expanded research efforts are necessary to
use this knowledge in exploring the epige-
netic effects of DES in relation to repro-
ductive tract malformations at the molecu-
lar level.
In addition to the estrogen receptor,
research on the role of "orphan receptors"
in environmental disease is promising.
Identification and characterization of
orphan receptors and their endogenous lg-
ands will provide a link to understanding
the molecular mechanisms through which
exogenous chemicals may exert toxic
effects and through which natural sub-
stances influence physiologic processes.
For example, a recently discovered member
of the nuclear receptor family apparently
recognizes a class of foreign chemicals
called peroxisome proliferators, which
includes industrial plasticizers, herbicides,
and hypolipidemic agents. Similarly, a
receptor from another gene family exists
for the ubiquitous xenobiotic dioxin, or
TCDD. A related example is the retinoids,
which regulate differentiation and growth
of a variety of epithelial tissues including
mammary gland, cervical, vaginal, and
uterine epithelium. Ongoing research at
NIEHS is directed toward understanding
the process of squamous differentiation in
gynecologic epithelial tissues by retinoids
and estrogens, and interactions between
the retinoic acid receptor and estrogen
receptor signaling pathways. Further
research is necessary to define these path-
ways at the molecular level and to elucidate
possible therapeutic applications of retin-
oids in breast and other cancers.
Role ofthe Environment in
Osteoporosis
Osteoporosis is a complex disorder of the
skeletal system characterized by decreased
bone mass, which leads to increased skele-
tal fragility and fracturing. The pathogen-
esis ofthis metabolic disorder is likely to be
multifactorial, involving genetic, racial,
and environmental factors including smok-
ing, diet, and alcohol. Interactions be-
tween the endocrine and immune systems
appear to play a key role in maintaining
the physiological homeostasis in bone
metabolism. Exposure to estrogenic sub-
stances, a number ofwhich are widespread
in the environment, can influence bone
pathology, as can exposure to heavy metals.
Researchers at NIEHS are using cell cul-
ture and animal studies to investigate the
molecular mechanisms of estrogen recep-
tor-mediated effects on bone development
and metabolism, and NIEHS-supported
studies are investigating the role of metals
such as aluminum and cadmium in osteo-
dystrophies. Important questions remain
regarding the competition of these metals
with calcium in bone deposition and reab-
sorption. Because the condition appears to
be more severe in women without ovarian
activity (e.g., postmenopausal), under-
standing the modulatory effects of estro-
gens on heavy-metal toxicity may con-
tribute to our knowledge ofthe process of
osteoporosis.
We now know, that early exposure to
DES at very low doses can affect bone den-
sity. Basic and clinical studies are now
focusing on the potential role that dose
and time of exposure to estrogenic sub-
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